Actively Recruiting

Age: 0Years +
FEMALE
NCT05739123

Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

Led by Sumitomo Pharma Switzerland GmbH · Updated on 2025-08-19

728

Participants Needed

1

Research Sites

520 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The Relugolix Pregnancy Registry is a prospective, observational cohort study designed to evaluate the association between relugolix-containing therapy exposure during pregnancy and subsequent maternal, fetal, and infant outcomes. Data will be collected from enrolled pregnant women and the healthcare providers (HCPs) involved in their care or the care of their infants, if applicable.

CONDITIONS

Official Title

Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

Who Can Participate

Age: 0Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Woman of any age
  • Currently or recently pregnant
  • Consent to participate
  • Authorization for her healthcare providers to provide data to the registry
  • For Cohort 1, exposure to at least one dose of relugolix-containing therapy during pregnancy
  • For Cohort 2, diagnosed with a condition possibly treated with relugolix but not exposed to it during pregnancy
Not Eligible

You will not qualify if you...

  • Pregnancy outcome occurred before first contact with the registry coordination center (retrospective enrollment)
  • Exposure to known teratogens or investigational medications during pregnancy
  • Lost to follow-up

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

PPD

Wilmington, North Carolina, United States, 28401

Actively Recruiting

Loading map...

Research Team

C

Clinical Trials at Myovant

CONTACT

M

Myovant Medical Monitor Study Director

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring | DecenTrialz